Copyright Reports & Markets. All rights reserved.

Global Oral Vaccination Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Oral Vaccination Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Rotavirus Vaccine
    • 1.3.3 Cholera Vaccine
    • 1.3.4 Oral Polio Vaccine
    • 1.3.5 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Oral Vaccination Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Public
    • 1.4.3 Private
  • 1.5 Global Oral Vaccination Market Size & Forecast
    • 1.5.1 Global Oral Vaccination Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Oral Vaccination Sales Quantity (2021-2032)
    • 1.5.3 Global Oral Vaccination Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck Oral Vaccination Product and Services
    • 2.1.4 Merck Oral Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 GSK
    • 2.2.1 GSK Details
    • 2.2.2 GSK Major Business
    • 2.2.3 GSK Oral Vaccination Product and Services
    • 2.2.4 GSK Oral Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 GSK Recent Developments/Updates
  • 2.3 Sanofi
    • 2.3.1 Sanofi Details
    • 2.3.2 Sanofi Major Business
    • 2.3.3 Sanofi Oral Vaccination Product and Services
    • 2.3.4 Sanofi Oral Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Sanofi Recent Developments/Updates
  • 2.4 Lanzhou Institute
    • 2.4.1 Lanzhou Institute Details
    • 2.4.2 Lanzhou Institute Major Business
    • 2.4.3 Lanzhou Institute Oral Vaccination Product and Services
    • 2.4.4 Lanzhou Institute Oral Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Lanzhou Institute Recent Developments/Updates
  • 2.5 Serum Institute
    • 2.5.1 Serum Institute Details
    • 2.5.2 Serum Institute Major Business
    • 2.5.3 Serum Institute Oral Vaccination Product and Services
    • 2.5.4 Serum Institute Oral Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Serum Institute Recent Developments/Updates
  • 2.6 Valneva
    • 2.6.1 Valneva Details
    • 2.6.2 Valneva Major Business
    • 2.6.3 Valneva Oral Vaccination Product and Services
    • 2.6.4 Valneva Oral Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Valneva Recent Developments/Updates
  • 2.7 Shanghai United Cell
    • 2.7.1 Shanghai United Cell Details
    • 2.7.2 Shanghai United Cell Major Business
    • 2.7.3 Shanghai United Cell Oral Vaccination Product and Services
    • 2.7.4 Shanghai United Cell Oral Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Shanghai United Cell Recent Developments/Updates
  • 2.8 Bibcol
    • 2.8.1 Bibcol Details
    • 2.8.2 Bibcol Major Business
    • 2.8.3 Bibcol Oral Vaccination Product and Services
    • 2.8.4 Bibcol Oral Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Bibcol Recent Developments/Updates
  • 2.9 Emergent BioSolutions
    • 2.9.1 Emergent BioSolutions Details
    • 2.9.2 Emergent BioSolutions Major Business
    • 2.9.3 Emergent BioSolutions Oral Vaccination Product and Services
    • 2.9.4 Emergent BioSolutions Oral Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Emergent BioSolutions Recent Developments/Updates
  • 2.10 Vabiotech
    • 2.10.1 Vabiotech Details
    • 2.10.2 Vabiotech Major Business
    • 2.10.3 Vabiotech Oral Vaccination Product and Services
    • 2.10.4 Vabiotech Oral Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Vabiotech Recent Developments/Updates
  • 2.11 Tiantan Biological
    • 2.11.1 Tiantan Biological Details
    • 2.11.2 Tiantan Biological Major Business
    • 2.11.3 Tiantan Biological Oral Vaccination Product and Services
    • 2.11.4 Tiantan Biological Oral Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Tiantan Biological Recent Developments/Updates
  • 2.12 EuBiologics
    • 2.12.1 EuBiologics Details
    • 2.12.2 EuBiologics Major Business
    • 2.12.3 EuBiologics Oral Vaccination Product and Services
    • 2.12.4 EuBiologics Oral Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 EuBiologics Recent Developments/Updates
  • 2.13 Panacea Biotec Ltd
    • 2.13.1 Panacea Biotec Ltd Details
    • 2.13.2 Panacea Biotec Ltd Major Business
    • 2.13.3 Panacea Biotec Ltd Oral Vaccination Product and Services
    • 2.13.4 Panacea Biotec Ltd Oral Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Panacea Biotec Ltd Recent Developments/Updates
  • 2.14 Bio-Med
    • 2.14.1 Bio-Med Details
    • 2.14.2 Bio-Med Major Business
    • 2.14.3 Bio-Med Oral Vaccination Product and Services
    • 2.14.4 Bio-Med Oral Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Bio-Med Recent Developments/Updates
  • 2.15 Halfkin Bio-Pharmaceuticals
    • 2.15.1 Halfkin Bio-Pharmaceuticals Details
    • 2.15.2 Halfkin Bio-Pharmaceuticals Major Business
    • 2.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccination Product and Services
    • 2.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Oral Vaccination by Manufacturer

  • 3.1 Global Oral Vaccination Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Oral Vaccination Revenue by Manufacturer (2021-2026)
  • 3.3 Global Oral Vaccination Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Oral Vaccination by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Oral Vaccination Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Oral Vaccination Manufacturer Market Share in 2025
  • 3.5 Oral Vaccination Market: Overall Company Footprint Analysis
    • 3.5.1 Oral Vaccination Market: Region Footprint
    • 3.5.2 Oral Vaccination Market: Company Product Type Footprint
    • 3.5.3 Oral Vaccination Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Oral Vaccination Market Size by Region
    • 4.1.1 Global Oral Vaccination Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Oral Vaccination Consumption Value by Region (2021-2032)
    • 4.1.3 Global Oral Vaccination Average Price by Region (2021-2032)
  • 4.2 North America Oral Vaccination Consumption Value (2021-2032)
  • 4.3 Europe Oral Vaccination Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Oral Vaccination Consumption Value (2021-2032)
  • 4.5 South America Oral Vaccination Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Oral Vaccination Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Oral Vaccination Sales Quantity by Type (2021-2032)
  • 5.2 Global Oral Vaccination Consumption Value by Type (2021-2032)
  • 5.3 Global Oral Vaccination Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Oral Vaccination Sales Quantity by Application (2021-2032)
  • 6.2 Global Oral Vaccination Consumption Value by Application (2021-2032)
  • 6.3 Global Oral Vaccination Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Oral Vaccination Sales Quantity by Type (2021-2032)
  • 7.2 North America Oral Vaccination Sales Quantity by Application (2021-2032)
  • 7.3 North America Oral Vaccination Market Size by Country
    • 7.3.1 North America Oral Vaccination Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Oral Vaccination Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Oral Vaccination Sales Quantity by Type (2021-2032)
  • 8.2 Europe Oral Vaccination Sales Quantity by Application (2021-2032)
  • 8.3 Europe Oral Vaccination Market Size by Country
    • 8.3.1 Europe Oral Vaccination Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Oral Vaccination Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Oral Vaccination Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Oral Vaccination Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Oral Vaccination Market Size by Region
    • 9.3.1 Asia-Pacific Oral Vaccination Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Oral Vaccination Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Oral Vaccination Sales Quantity by Type (2021-2032)
  • 10.2 South America Oral Vaccination Sales Quantity by Application (2021-2032)
  • 10.3 South America Oral Vaccination Market Size by Country
    • 10.3.1 South America Oral Vaccination Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Oral Vaccination Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Oral Vaccination Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Oral Vaccination Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Oral Vaccination Market Size by Country
    • 11.3.1 Middle East & Africa Oral Vaccination Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Oral Vaccination Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Oral Vaccination Market Drivers
  • 12.2 Oral Vaccination Market Restraints
  • 12.3 Oral Vaccination Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Oral Vaccination and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Oral Vaccination
  • 13.3 Oral Vaccination Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Oral Vaccination Typical Distributors
  • 14.3 Oral Vaccination Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Oral Vaccination market size was valued at US$ 2976 million in 2025 and is forecast to a readjusted size of US$ 4221 million by 2032 with a CAGR of 5.2% during review period.
    Oral vaccines have several attractive features compared with parenteral vaccines, but studies on their use have been limited almost exclusively to protection against mucosally transmitted pathogens.
    The oral vaccination market is primarily driven by the advantages it offers in terms of ease of administration, increased patient compliance, and cost-effectiveness compared to traditional injectable vaccines. Oral vaccines provide a non-invasive and painless immunization method, particularly beneficial for pediatric and elderly populations. Additionally, their potential to elicit both systemic and mucosal immunity enhances protection against pathogens that enter the body through mucosal surfaces, such as the respiratory and gastrointestinal tracts, further fueling their adoption. However, the market also faces challenges, including the complex formulation and delivery of oral vaccines, which may affect their stability and efficacy. Developing vaccines that can withstand acidic environments and enzymatic degradation in the gastrointestinal tract poses significant scientific and manufacturing challenges. Moreover, gaining regulatory approvals and ensuring public acceptance of oral vaccines may require extensive clinical data and educational efforts to dispel misconceptions about their safety and efficacy. To overcome these challenges, the industry is focused on research and innovation to improve oral vaccine formulation and delivery technologies. Collaborations between vaccine developers, research institutions, and regulatory authorities are crucial in driving the growth of the oral vaccination market and expanding access to effective and accessible immunization options, particularly in regions with limited healthcare infrastructure.
    This report is a detailed and comprehensive analysis for global Oral Vaccination market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Oral Vaccination market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Oral Vaccination market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Oral Vaccination market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Oral Vaccination market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Oral Vaccination
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Oral Vaccination market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, Emergent BioSolutions, Vabiotech, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Oral Vaccination market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Rotavirus Vaccine
    Cholera Vaccine
    Oral Polio Vaccine
    Other
    Market segment by Application
    Public
    Private
    Major players covered
    Merck
    GSK
    Sanofi
    Lanzhou Institute
    Serum Institute
    Valneva
    Shanghai United Cell
    Bibcol
    Emergent BioSolutions
    Vabiotech
    Tiantan Biological
    EuBiologics
    Panacea Biotec Ltd
    Bio-Med
    Halfkin Bio-Pharmaceuticals
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Oral Vaccination product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Oral Vaccination, with price, sales quantity, revenue, and global market share of Oral Vaccination from 2021 to 2026.
    Chapter 3, the Oral Vaccination competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Oral Vaccination breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Oral Vaccination market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Vaccination.
    Chapter 14 and 15, to describe Oral Vaccination sales channel, distributors, customers, research findings and conclusion.

    Buy now